Letters
Unintended effects of statins
Yellow card reports add to data
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3697 (Published 13 July 2010) Cite this as: BMJ 2010;341:c3697
- Katherine Davidson, senior pharmacist1,
- Sheena Kerr, lead pharmacist2,
- Moira Kinnear, head of pharmacy education research and development 2,
- D Nicholas Bateman, professor in clinical toxicology3
- 1Royal Infirmary of Edinburgh, Edinburgh EH16 4SA
- 2Western General Hospital, Edinburgh EX4 2XU
- 3YCC Scotland, Royal Infirmary of Edinburgh
- nick.bateman{at}luht.scot.nhs.uk
Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.